Title : Diallyl thiosulfinate enhanced the anti-cancer activity of dexamethasone in the side population cells of multiple myeloma by promoting miR-127-3p and deactivating the PI3K/AKT signaling pathway.

Pub. Date : 2021 Feb 6

PMID : 33549034






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Diallyl thiosulfinate enhanced the anti-cancer activity of dexamethasone in the side population cells of multiple myeloma by promoting miR-127-3p and deactivating the PI3K/AKT signaling pathway. Dexamethasone AKT serine/threonine kinase 1 Homo sapiens
2 In addition, the combination of DATS+Dex promoted miR-127-3p expression and inhibited PI3K, p-AKT, and p-mTOR expression in SP cells. Dexamethasone AKT serine/threonine kinase 1 Homo sapiens
3 Additionally, knockdown of miR-127-3p activated the PI3K/AKT/mTOR signaling pathway in MM SP cells cotreated with DATS+Dex. Dexamethasone AKT serine/threonine kinase 1 Homo sapiens
4 CONCLUSION: We demonstrated that cotreatment with DATS+Dex reduced cell proliferation, promoted apoptosis, and caused cell cycle arrest of MM SP cells by promoting miR-127-3p expression and deactivating the PI3K/AKT/mTOR signaling pathway. Dexamethasone AKT serine/threonine kinase 1 Homo sapiens